Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Jun-23 6:06 PM View:  | Denali Therapeutics Inc. (DNLI) | 01-Jun-23 | Grant | 4,216 | -- | -- | < 1% 2.11M to 2.11M | |
| 05-Jan-23 4:16 PM View: | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Grant | 165 | -- | -- | 7% 2.27K to 2.43K | |
| 05-Jan-23 4:16 PM View: | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Grant | 165 | -- | -- | 7% 2.27K to 2.43K | |
| 28-Nov-22 7:30 PM View: | Denali Therapeutics Inc. (DNLI) | 23-Nov-22 | Sale (Planned) | 20,000 | $30.48 | $609,600.00 | (< 1%) 2.13M to 2.11M | |
| 03-Nov-22 5:37 PM View: | Denali Therapeutics Inc. (DNLI) | 02-Nov-22 | Sale (Planned) | 11,252 | $30.33 | $341,273.00 | (< 1%) 2.14M to 2.13M | |
| 03-Nov-22 5:37 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Nov-22 | Sale (Planned) | 8,748 | $30.20 | $264,190.00 | (< 1%) 2.15M to 2.14M | |
| 03-Oct-22 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 03-Oct-22 | Option Exercise | 3,612 | $413.33 | $1,492,950.00 | 159% 2.27K to 5.88K | |
| 03-Oct-22 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 03-Oct-22 | Planned Option Sale | 3,612 | $718.00 | $2,593,420.00 | (61%) 5.88K to 2.27K | |
| 03-Oct-22 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 30-Sep-22 | Option Exercise | 3,428 | $413.33 | $1,416,900.00 | 151% 2.27K to 5.7K | |
| 03-Oct-22 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 30-Sep-22 | Planned Option Sale | 3,428 | $698.00 | $2,392,740.00 | (60%) 5.7K to 2.27K | |
| 03-Oct-22 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 29-Sep-22 | Option Exercise | 3,798 | $413.33 | $1,569,830.00 | 167% 2.27K to 6.07K | |
| 03-Oct-22 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 29-Sep-22 | Planned Option Sale | 3,798 | $691.07 | $2,624,680.00 | (63%) 6.07K to 2.27K | |
| 30-Sep-22 4:50 PM View: | Denali Therapeutics Inc. (DNLI) | 28-Sep-22 | Sale (Planned) | 20,000 | $30.82 | $616,304.00 | (< 1%) 2.17M to 2.15M | |
| 25-Aug-22 6:11 PM View: | Denali Therapeutics Inc. (DNLI) | 23-Aug-22 | Sale (Planned) | 20,000 | $31.61 | $632,282.00 | (< 1%) 2.19M to 2.17M | |
| 27-Jul-22 6:49 PM View: | Denali Therapeutics Inc. (DNLI) | 25-Jul-22 | Market Sale | 20,000 | $35.61 | $712,110.00 | (< 1%) 2.21M to 2.19M | (13%) |
| 27-Jun-22 8:54 PM View: | Denali Therapeutics Inc. (DNLI) | 24-Jun-22 | Disposition | 46,750 | $30.61 | $1,430,970.00 | (2%) 2.25M to 2.21M | |
| 27-Jun-22 8:54 PM View: | Denali Therapeutics Inc. (DNLI) | 23-Jun-22 | Disposition | 13,250 | $31.10 | $412,076.00 | (< 1%) 2.27M to 2.25M | |
| 06-Jun-22 8:09 PM View: | Denali Therapeutics Inc. (DNLI) | 02-Jun-22 | Grant | 5,986 | -- | -- | < 1% 2.26M to 2.27M | |
| 25-Mar-22 5:57 PM View: | Denali Therapeutics Inc. (DNLI) | 23-Mar-22 | Sale | 20,000 | $33.83 | $676,582.00 | (< 1%) 2.28M to 2.26M | |
| 23-Mar-22 4:01 PM View: | Regeneron Pharmaceuticals I... (REGN) | 21-Mar-22 | Option Exercise | 7,439 | $380.95 | $2,833,890.00 | 328% 2.27K to 9.71K | |
| 23-Mar-22 4:01 PM View: | Regeneron Pharmaceuticals I... (REGN) | 21-Mar-22 | Planned Option Sale | 7,439 | $690.00 | $5,132,910.00 | (77%) 9.71K to 2.27K | |
| 18-Mar-22 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 17-Mar-22 | Option Exercise | 7,830 | $376.69 | $2,949,480.00 | 345% 2.27K to 10.1K | |
| 18-Mar-22 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 17-Mar-22 | Planned Option Sale | 7,830 | $680.00 | $5,324,400.00 | (78%) 10.1K to 2.27K | |
| 18-Mar-22 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 16-Mar-22 | Option Exercise | 4,361 | $374.12 | $1,631,540.00 | 192% 2.27K to 6.63K | |
| 18-Mar-22 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 16-Mar-22 | Planned Option Sale | 4,361 | $675.00 | $2,943,680.00 | (66%) 6.63K to 2.27K | |
| 05-Jan-22 4:23 PM View: | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-22 | Grant | 191 | -- | -- | 9% 2.08K to 2.27K | |
| 30-Dec-21 9:59 PM View: | Denali Therapeutics Inc. (DNLI) | 30-Dec-21 | Market Sale | 20,047 | $45.36 | $909,361.00 | (< 1%) 2.5M to 2.48M | |
| 30-Dec-21 9:59 PM View: | Denali Therapeutics Inc. (DNLI) | 29-Dec-21 | Market Sale | 32,104 | $43.88 | $1,408,620.00 | (1%) 2.53M to 2.5M | |
| 30-Dec-21 9:59 PM View: | Denali Therapeutics Inc. (DNLI) | 28-Dec-21 | Market Sale | 10,980 | $44.37 | $487,219.00 | (< 1%) 2.54M to 2.53M | |
| 17-Feb-22 10:00 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Dec-21 | Gift | 200,000 | -- | -- | (8%) 2.48M to 2.28M | |
| 10-Dec-21 5:41 PM View: | Regeneron Pharmaceuticals I... (REGN) | 09-Dec-21 | Option Exercise | 3,784 | $371.40 | $1,405,380.00 | 182% 2.08K to 5.86K | |
| 10-Dec-21 5:41 PM View: | Regeneron Pharmaceuticals I... (REGN) | 09-Dec-21 | Market Option Sale (Planned) | 3,784 | $665.00 | $2,516,360.00 | (65%) 5.86K to 2.08K | |
| 30-Dec-21 9:59 PM View: | Denali Therapeutics Inc. (DNLI) | 04-Oct-21 | Gift | 300,000 | -- | -- | 12% 2.54M to 2.84M | |
| 30-Dec-21 9:59 PM View: | Denali Therapeutics Inc. (DNLI) | 04-Oct-21 | Gift | 300,000 | -- | -- | (11%) 2.84M to 2.54M | |
| 15-Sep-21 4:02 PM View: | Regeneron Pharmaceuticals I... (REGN) | 13-Sep-21 | Option Exercise | 12,750 | $273.67 | $3,489,290.00 | 614% 2.08K to 14.83K | |
| 15-Sep-21 4:02 PM View: | Regeneron Pharmaceuticals I... (REGN) | 13-Sep-21 | Market Option Sale (Planned) | 12,750 | $641.71 | $8,181,830.00 | (86%) 14.83K to 2.08K | |
| 08-Jun-21 5:10 PM View: | Denali Therapeutics Inc. (DNLI) | 07-Jun-21 | Option Exercise | 94,378 | $18.70 | $1,765,280.00 | 4% 2.54M to 2.64M | |
| 08-Jun-21 5:10 PM View: | Denali Therapeutics Inc. (DNLI) | 07-Jun-21 | Market Option Sale (Planned) | 94,378 | $70.35 | $6,639,520.00 | (4%) 2.64M to 2.54M | |
| 04-Jun-21 6:37 PM View: | Denali Therapeutics Inc. (DNLI) | 02-Jun-21 | Grant | 2,074 | -- | -- | < 1% 2.54M to 2.54M | |
| 24-May-21 8:05 PM View: | Denali Therapeutics Inc. (DNLI) | 24-May-21 | Market Sale (Planned) | 8,806 | $60.03 | $528,580.00 | (< 1%) 2.55M to 2.54M | 2% |
| 24-May-21 8:05 PM View: | Denali Therapeutics Inc. (DNLI) | 21-May-21 | Market Sale (Planned) | 37,957 | $60.13 | $2,282,470.00 | (1%) 2.59M to 2.55M | 2% |
| 05-May-21 4:14 PM View: | Denali Therapeutics Inc. (DNLI) | 03-May-21 | Market Sale (Planned) | 3,237 | $60.11 | $194,589.00 | (< 1%) 2.59M to 2.59M | 7% |
| 05-Apr-21 4:10 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Apr-21 | Market Sale (Planned) | 50,000 | $56.62 | $2,831,070.00 | (2%) 2.64M to 2.59M | 1% |
| 03-Mar-21 4:20 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Mar-21 | Market Sale (Planned) | 100,000 | $66.22 | $6,622,210.00 | (4%) 2.74M to 2.64M | 5% |
| 05-Jan-21 4:11 PM View: | Regeneron Pharmaceuticals I... (REGN) | 04-Jan-21 | Grant | 248 | -- | -- | 14% 1.83K to 2.08K | |
| 18-Jun-20 9:41 PM View: | Denali Therapeutics Inc. (DNLI) | 16-Jun-20 | Market Sale | 400,000 | $26.10 | $10,440,000.00 | (13%) 3.14M to 2.74M | |
| 08-May-20 4:03 PM View: | Regeneron Pharmaceuticals I... (REGN) | 06-May-20 | Option Exercise | 15,000 | $177.82 | $2,667,300.00 | 820% 1.83K to 16.83K | |
| 08-May-20 4:03 PM View: | Regeneron Pharmaceuticals I... (REGN) | 06-May-20 | Market Option Sale | 15,000 | $563.97 | $8,459,500.00 | (89%) 16.83K to 1.83K | 13% |
| 14-Feb-20 4:10 PM View: | Regeneron Pharmaceuticals I... (REGN) | 13-Feb-20 | Option Exercise | 14,279 | $53.08 | $757,944.00 | 780% 1.83K to 16.11K | |
| 14-Feb-20 4:10 PM View: | Regeneron Pharmaceuticals I... (REGN) | 13-Feb-20 | Market Option Sale | 14,279 | $400.01 | $5,711,710.00 | (89%) 16.11K to 1.83K | (22%) |